TCL Archive Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49 April 4, 1997
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013